OvaScience (OVAS) Misses Q4 EPS by 6c

OvaScience (NASDAQ: OVAS) reported Q4 EPS of ($0.64), $0.06 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $121 thousand versus the consensus estimate of $114 thousand.

For earnings history and earnings-related data on OvaScience (OVAS) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• JPMorgan Upgrades Largan Precision Co Ltd. (3008:TT) to Overweight
• Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight